TABLE 3.

Ratings of the value of VC in pre-given application scenarios [mean ± standard deviation (n), Likert scale (very useful)–6 (not at all useful)].

Scenario	Digital user Mean ± standard deviation Likert scale 1 (very useful)–6 (not at all useful)	Digital non-user Mean ± standard deviation Likert scale 1 (very useful)–6 (not at all useful)
First presentation to rheumatologist/screening for suspected IRD*	4.7 ± 1.4	3.9 ± 1.7
Follow-up presentation*	2.4 ± 11.1	2.0 ± 1.2
Clinical assessment	2.7 ± 1.1	2.9 ± 1.6
Discussion of findings (e.g., laboratory)*	2.1 ± 1.3	1.6 ± 1.3
Information on new therapy/medication*	2.9 ± 1.6	1.8 ± 0.9
Information on new/more elaborated diagnostic procedures*	2.8 ± 1.6	1.9 ± 1.2
Talk to relatives	2.8 ± 1.6	2.4 ± 1.5
Stable remission*	1.9 ± 1.1	1.5 ± 1.1
Moderate disease activity	3.3 ± 1.3	3.2 ± 1.3
Flare/high disease activity	4.3 ± 1.6	4.3 ± 1.3

*Significant differences with p-values < 0.05 (Wilcoxon-Mann–Whitney-Test).